RQLBYRLLVQBUME-UHFFFAOYSA-N
C37H46F5NOSi — CID 151760406
Data last refreshed: (MolForge compound catalog, from PubChem)
About RQLBYRLLVQBUME-UHFFFAOYSA-N
RQLBYRLLVQBUME-UHFFFAOYSA-N (PubChem CID 151760406) has the molecular formula C37H46F5NOSi and a molecular weight of 643.86 g/mol. Its IUPAC name is [2-cyclopentyl-4-(4-fluorophenyl)-3-[fluoro-[4-(trifluoromethyl)phenyl]methyl]-7,7-dimethyl-6,8-dihydro-5H-quinolin-5-yl]oxy-(2,2-dimethylpropyl)-dimethylsilane.
Molecular Properties
| Compound Name | RQLBYRLLVQBUME-UHFFFAOYSA-N |
|---|---|
| PubChem CID | 151760406 |
| Molecular Formula | C37H46F5NOSi |
| Molecular Weight | 643.86 g/mol |
| Exact Mass | 643.33 |
| IUPAC Name | [2-cyclopentyl-4-(4-fluorophenyl)-3-[fluoro-[4-(trifluoromethyl)phenyl]methyl]-7,7-dimethyl-6,8-dihydro-5H-quinolin-5-yl]oxy-(2,2-dimethylpropyl)-dimethylsilane |
| SMILES | CC(C)(C)C[Si](C)(C)OC1CC(C)(C)Cc2nc(C3CCCC3)c(C(F)c3ccc(C(F)(F)F)cc3)c(-c3ccc(F)cc3)c21 |
| InChI | InChI=1S/C37H46F5NOSi/c1-35(2,3)22-45(6,7)44-29-21-36(4,5)20-28-31(29)30(23-14-18-27(38)19-15-23)32(34(43-28)25-10-8-9-11-25)33(39)24-12-16-26(17-13-24)37(40,41)42/h12-19,25,29,33H,8-11,20-22H2,1-7H3 |
| InChIKey | RQLBYRLLVQBUME-UHFFFAOYSA-N |
| XLogP | 11.90 |
| TPSA | 22.12 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 45 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 643.86 |
| LogP ≤ 5 | 11.90 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 2 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'heavy_metal', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 151760406 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.